Title : Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence - Rollema_2010_Br.J.Pharmacol_160_334 |
Author(s) : Rollema H , Shrikhande A , Ward KM , Tingley FD, 3rd , Coe JW , O'Neill BT , Tseng E , Wang EQ , Mather RJ , Hurst RS , Williams KE , De Vries M , Cremers T , Bertrand S , Bertrand D |
Ref : British Journal of Pharmacology , 160 :334 , 2010 |
Abstract : Rollema_2010_Br.J.Pharmacol_160_334 |
ESTHER : Rollema_2010_Br.J.Pharmacol_160_334 |
PubMedSearch : Rollema_2010_Br.J.Pharmacol_160_334 |
PubMedID: 20331614 |
Rollema H, Shrikhande A, Ward KM, Tingley FD, 3rd, Coe JW, O'Neill BT, Tseng E, Wang EQ, Mather RJ, Hurst RS, Williams KE, De Vries M, Cremers T, Bertrand S, Bertrand D (2010)
Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence
British Journal of Pharmacology
160 :334
Rollema H, Shrikhande A, Ward KM, Tingley FD, 3rd, Coe JW, O'Neill BT, Tseng E, Wang EQ, Mather RJ, Hurst RS, Williams KE, De Vries M, Cremers T, Bertrand S, Bertrand D (2010)
British Journal of Pharmacology
160 :334